Attachment 1 Comprehensive Drug Products list.xlsx
XLSX spreadsheet 26 KB Posted
- Solicitation number
- 75F40126Q132721
About this file
This is a Comprehensive Drug Products List that serves as an attachment to a pharmaceutical solicitation for the Food and Drug Administration's Center for Drug Evaluation and Research (CDER). The document outlines a drug purchase forecast containing 96 pharmaceutical products with varying formulations, strengths, package sizes, NDC numbers, and manufacturers/distributors. Each product is listed with a quantity of one unit designated for evaluation purposes only, with notation that actual ordering quantities may vary.
The products span multiple therapeutic categories including respiratory inhalers (Advair Diskus, Spiriva Respimat, Trelegy Ellipta), injectable medications (Abraxane, AmBisome, Exondys 51), oral tablets and capsules (Concerta, Tamiflu, Ziagen), ophthalmic suspensions (Tobradex, Tobrex), intrauterine devices (Mirena, Paragard T 380A, Skyla), and specialty pharmaceuticals such as Narcan, Vivitrol, and Victoza. The spreadsheet includes columns for five ordering periods with unit pricing fields, though all pricing cells display $0.00, indicating this is a template or evaluation document where actual pricing has not yet been populated. The list also contains a total evaluated price row across all five ordering periods. This comprehensive product list establishes the scope of pharmaceutical items potentially subject to ordering under the CDER Research Studies Indefinite Delivery Indefinite Quantity (IDIQ) contract vehicle.
View the file
Other files
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Drug purchase forecast
| Product Name | Strength | Size | NDC Number (if avail) | Manufacturer/ Distributor | Qty for evaluation purposes only (may vary when ordering) | Ordering Period 1 Price/ Unit | Ordering Period 2 Price/ Unit | Ordering Period 3 Price/ Unit | Ordering Period 4 Price/ Unit | Ordering Period 5 Price/ Unit | Notes |
| Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate | 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg | 100 tablets/bottle | 00527-0766-37 | 1 | |||||||
| Budesonide; Formoterol Fumarate Glycopyrrolate Metered Inhalation Aerosol | 0.16 mg/inh; 0.005mg/inh; 0.0072 mg/inh | 1 inhaler/unit | 1 | ||||||||
| ABRAXANE (paclitaxel albumin-bound injectable suspension) | 100mg/vial | 1 in 1 CARTON | 68817-134-50 | 1 | |||||||
| ADASUVE (loxapine inhalation aerosol powder) | 10mg | 5 in 1 CARTON | 10885-003-05 | 1 | |||||||
| ADRENACLICK (epinephrine injection) | EQ 0.15MG/DELIVERY | 1 | |||||||||
| ADVAIR DISKUS (fluticasone propionate and salmeterol powder) | 0.5MG/INH; EQ 0.05MG BASE/INH | 60 in 1 INHALER | 0173-0695-00 | 1 | |||||||
| AMBISOME (amphotericin B injection, powder, lyophilized, for solution) | 50mg/vial | 1 vial | 0469-3051-30 | 1 | |||||||
| AZILECT (Rasagiline Mesylate) Tablet | 1mg | bottle of 30 | 1 | ||||||||
| BYDUREON BCISE (exenatide injection, suspension, extended release) | 2 MG | 1 in 1 carton and 4 in 1 carton | 0310-6540-85 and 0310-6540-04 | 1 | |||||||
| CARAFATE (sucralfate suspension) | 1GM/10ML | 1 | |||||||||
| CONCERTA (methylphenidate hydrochloride tablet, extended release) | 54mg | bottle of 100 | 50458-587-01 | 1 | |||||||
| CORGARD (nadolol tablet) | 80mg | bottle of 100 | 1 | ||||||||
| CUPRIMINE (penicillamine capsule) | 250mg | bottle of 100 | 1 | ||||||||
| DEFINITY (perflutren injection, suspension) | 6.52mg/mL | Box containing 16 vials (2mL) | 11994-011-16 | 1 | |||||||
| DEPEN (penicillamine tablet) | 250mg | bottle of 100 | 0037-4401-01 | 1 | |||||||
| DEXILANT (dexlansoprazole capsule, delayed release) | 30mg | 1 | |||||||||
| DIPRIVAN (propofol injection, emulsion) | 10mg/mL | 1 | |||||||||
| DOXIL (doxorubicin liposomal injection) | 20mg/10mL | 1 | |||||||||
| Effexor XR (venlafaxine hydrochloride capsule, extended release) | 150mg | 1 | |||||||||
| EPIPEN JR (epinephrine injection) | 0.15MG/DELIVERY | 1 | |||||||||
| EXONDYS 51(eteplirsen injection) | 100mg/2mL | 60923-363-02 | 1 | ||||||||
| EXPAREL (bupivacaine injection, suspension, liposomal) | 266MG/20ML (13.3MG/ML) | Box containing 10 vials, each vial containing 20 mL | 1 | ||||||||
| FIRMAGON (degarelix) | 120mg/vial | 1 | |||||||||
| FORTEO (teriparatide injection, solution) | 0.6MG/2.4ML (0.25MG/ML) | 1 | |||||||||
| HYSINGLA ER (hydrocodone bitartrate tablet, extended release) | 120mg | 1 | |||||||||
| INJECTAFER (ferric carboxymaltose injection injection, solution) | 750MG IRON/15ML (50MG IRON/ML) | 1 | |||||||||
| LOTEMAX (loteprednol etabonate suspension/drops) | 0.50% | 1 | |||||||||
| LUMASON (sulfur hexaflouride) | 60.7MG/25MG | 0270-7099-16 | 1 | ||||||||
| MIACALCIN (calcitonin salmon injection, solution) | 200IU/ml | 1 in 1 carton | 67457-675-02 | 1 | |||||||
| MIRENA (levonorgestrel intrauterine device) | 52mg | 1 | |||||||||
| NARCAN (naloxone hydrochloride Spray) | 4MG/SPRAY | 1 | |||||||||
| NEXIUM (esomeprazole magnesium granule, delayed release) | EQ 40MG BASE/PACKET | 1 | |||||||||
| Ozurdex (dexamethasone implant) | 0.7mg | 1 | |||||||||
| PARAGARD T 380A (copper intrauterine device) | 309MG/COPPER | 1 | |||||||||
| PENTASA (mesalamine capsule) | 500mg | 1 | |||||||||
| PREMARIN (conjugated estrogens vaginal cream) | 0.625MG/GM | 1 | |||||||||
| PREVACID (lansoprazole tablet, orally disintegrating, delayed release) | 30mg | 1 | |||||||||
| PROAIR RESPICLICK (albuterol sulfate powder, metered) | EQ 0.090MG BASE/INH | 1 | |||||||||
| PROTONIX DELAYED-RELEASE(pantoprazole sodium granule, delayed release) | 40mg | 1 | |||||||||
| QVAR REDIHALER (beclomethasone dipropionate hfa aerosol, metered) | 0.04MG/INH | 1 | |||||||||
| RASUVO (methotrexate injection, solution) | 7.5MG/0.15ML (7.5MG/0.15ML) | 1 | |||||||||
| RESTASIS (cyclosporine emulsion) | 0.05% | 1 | |||||||||
| RISPERDAL CONSTA (risperidone injection) | 50MG/VIAL | 1 | |||||||||
| SANDOSTATIN LAR DEPOT (octreotide acetate) | 30mg | 1 | |||||||||
| SKYLA (levonorgestrel intrauterine device) | 13.5mg | 1 | |||||||||
| SPINRAZA (nusinersen injection, solution) | 12mg/5mL | 64406-058-01 | 1 | ||||||||
| SPIRIVA RESPIMAT (tiotropium bromide inhalation spray spray, metered) | EQ 0.0025MG BASE/INH | 0597-0100-61 | 1 | ||||||||
| STRIVERDI RESPIMAT (olodaterol respimat inhalation spray spray, metered) | EQ 0.0025MG BASE/INH | 0597-0192-61 | 1 | ||||||||
| Tacrolimus | 1 | ||||||||||
| TAMIFLU (oseltamivir phosphate capsule) | EQ 75MG BASE | 1 | |||||||||
| TENORMIN (atenolol tablet) | 100mg | bottle of 100 | 1 | ||||||||
| TESTOPEL (testosterone pellet) | 75mg | 1 | |||||||||
| TIMOPTIC-XE (timolol maleate solution) | 0.25% | 1 | |||||||||
| TOBI PODHALER (tobramycin capsule) | 28MG | 1 | |||||||||
| TOBREX (tobramycin ophthalmic suspension) | 0.30% | 1 | |||||||||
| TOBRADEX (tobramycin/dexamethasone ophthalmic suspension) | 0.3%/0.1% | 1 | |||||||||
| TOBRADEX ST (tobramycin/dexamethasone ophthalmic suspension) | 0.3%/0.05% | 1 | |||||||||
| TRELEGY ELLIPTA (fluticasone furoate, umeclidinium bromide and vilanterol trifenatate powder) | 0.1MG/INH;EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH | 0173-0887-10 or 0173-0887-14 | 1 | ||||||||
| TRELSTAR (triptorelin pamoate) | 22.5mg | 1 | |||||||||
| TYMLOS (abaloparatide injection, solution) | 3.12MG/1.56ML (2MG/ML) | 1 | |||||||||
| TYVASO (treprostinil inhalant) | 0.6MG/ML | 1 | |||||||||
| UCERIS (budesonide aerosol, rectal foam) | 2MG/ACTUATION | 1 | |||||||||
| VELPHORO (sucroferric oxyhydroxide tablet, chewable) | 500mg | 49230-645-51 | 1 | ||||||||
| VELTASSA (patiromer powder, for suspensionr) | EQ 8.4GM BASE/PACKET | 1 | |||||||||
| VICTOZA (liraglutide injection) | 18MG/3ML (6MG/ML) | 1 | |||||||||
| VIDAZA (azacitidine injection, powder, lyophilized, for solution) | 100mg/vial | 1 | |||||||||
| VIVITROL (naltrexone injection) | 380mg | 1 | |||||||||
| VYXEOS (daunorubicin and cytarabine liposome injection, powder, lyophilized, for suspension) | 44mg/100mg | 1 | |||||||||
| XERESE (acyclovir and hydrocortisone cream) | 5%; 1% | 1 in 1 CARTON | 0187-5104-01 | 1 | |||||||
| XHANCE (fluticasone propionate spray, metered) | 0.093MG | 1 | |||||||||
| XOPENEX HFA (levalbuterol tartrate aerosol, metered) | EQ 0.045 MG BASE/INH | 1 | |||||||||
| XTAMPZA ER (oxycodone capsule, extended release) | 36mg | 1 | |||||||||
| XULTOPHY 100/3.6 (insulin degludec and liraglutide injection, solution) | 100 UNITS/ML;3.6MG/ML | 1 | |||||||||
| ZIAGEN (abacavir sulfate tablet, film coated) | EQ 300MG BASE | 1 | |||||||||
| Total Evaluated Price | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
File details come from the government source that posted it. Updated .